Vivek Subbiah: Now that we have landed in the moon off to Mars

Vivek Subbiah shared a post on X:

”To the moon! Huge congratulations to Toni Choueiri for The Lancet and The New England Journal of Medicine paper at ESMO24! Now that we have landed in the moon – off to Mars! Exhilarating discussions about one of the greatest oncology meetings ever with Toni Choueiri, Sumanta K. Pal. Stay tuned.”

Source: Vivek Subbiah/X

Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA). He is the former Executive Director of Oncology Research and former Associate Professor in the Department of Investigational Cancer Therapeutics at the MD Anderson Cancer He focuses on translational cancer research and the design and implementation of early-phase biomarker-driven clinical trials. His work specifically targets antibody-drug conjugates, radiopharmaceuticals, immunoconjugates, and basket trials.